Board of Directors

Jonathan Peacock_402x268_Final
  

Jonathan Peacock

British, 62 
Board Member (Independent, elected by the General Meeting);  Member of the Audit and Finance Committee and the Compensation Committee 
First elected 2020, current term expires 2021

Special Competencies
Extensive experience in corporate finance, strategy and international expansion in the pharmaceutical industry. Involved in several large and small acquisitions and partnerships of commercial, pipeline and research assets covering diverse global markets as CFO at Novartis Pharma and CFO at Amgen. Jonathan Peacock holds a degree in Economics, is a chartered accountant and has a background as a partner at McKinsey and Price Waterhouse.

Current Board Positions
Chairman: Arix Bioscience plc, Bellerophon Therapeutics Inc

Member: Avantor Inc, W20 Group, Socati Corporation, Natural History Museum of Los Angeles

Back To Board of Directors